Catalyst Wire Dossier Catalyst Wire Dossier

HAC 22L Injection

· AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HAC 22L Injection, covering 2025-12-26 to 2025-12-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Adverse Events and Effectiveness of HAC 22L Injection for Mid-Face Volume in Adult Participants [Phase 3]

See pricing